| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3166d2820b5872ab84d235e5fae1d45 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2982 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-04 |
| filingDate |
2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19bbd2f2a54cdaa59bb221f227e50742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c917a2090ef5521529accadef0cd9bc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c1e32579c9d3ec7eb50a6ca6e74019b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baceec7ae14d9827d6f78eb82209a445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_995d98e7a7f6468fd043f0e735123058 |
| publicationDate |
2015-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015051228-A1 |
| titleOfInvention |
Amorphous form of linagliptin and process for preparation thereof |
| abstract |
The present invention relates to an amorphous form of linagliptin and processes for the preparation thereof. The invention also relates to a pharmaceutical composition comprising therapeutically effective amount of an amorphous form of linagliptin and use of said composition for treatment of diabetes especially type-I or type-II, prediabetes or reduction of glucose tolerance. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9867829-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021107476-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015224102-A1 |
| priorityDate |
2012-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |